Stock Screener App

Frei -

Installieren

0.85

9.52% 0.074

Fractyl Health Inc (GUTS)

Überblick Nachrichten Preisverlauf Forum Prognose

Fractyl Health Inc Aktie (GUTS) Neueste Nachrichten

GUTS SEC FilingsFractyl Health 10-K, 10-Q, 8-K Forms - Stock Titan

Fractyl Health director Ajay Royan buys $19,596 in company stock - Investing.com UK

Fractyl Health (NASDAQ: GUTS) director adds 23,000 shares in open-market buy - Stock Titan

Fractyl Health, Inc. 8-K Filing June 2026: Company Information, Nasdaq Listing, and Executive Details - Minichart

Fractyl Health Inc (GUTS) Cleared for RJVA-001 Trial. Let’s Look At Funding - Insider Monkey

Fractyl Health director William Bradley buys $50,328 in stock - Investing.com

Fractyl Health (NASDAQ: GUTS) 2026 meeting backs board and auditor - Stock Titan

Fractyl Health (GUTS) director buys stock and receives 22,500 options - Stock Titan

Fractyl Health (GUTS) awards 22,500 stock options to board director - Stock Titan

Fractyl Health (GUTS) awards director 22,500 options at $0.7318 - Stock Titan

Fractyl Health (GUTS) director Marc Elia receives 22,500-share stock option grant - Stock Titan

Fractyl Health (GUTS) director receives 22,500-stock-option board compensation grant - Stock Titan

Director Clive Meanwell gets 22,500 options at Fractyl Health (GUTS) - Stock Titan

Fractyl Health (NASDAQ: GUTS) director buys shares and receives options - Stock Titan

Fractyl Health (GUTS) CEO buys 25,000 open-market shares - Stock Titan

Fractyl Health CFO Smith Weber Lara purchases $13,708 in stock By Investing.com - Investing.com South Africa

Fractyl Health CFO Smith Weber Lara purchases $13,708 in stock - Investing.com

[Form 4] FRACTYL HEALTH, INC. Insider Trading Activity - Stock Titan

Fractyl Health reports one-year data on weight maintenance therapy - Investing.com UK

GUTS Reiterates by HC Wainwright & Co. -- Price Target Maintained at $8.00 - GuruFocus

Fractyl Health Reports Positive One-Year Results from REVEAL-1 Open-Label Study of Revita Procedure for Post-GLP-1 Weight Maintenance - marketscreener.com

Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure - markets.businessinsider.com

Fractyl Health Highlights One-Year Revita Obesity Results - TipRanks

Fractyl Health reports one-year data on weight maintenance therapy By Investing.com - Investing.com South Africa

Fractyl Health Reports Positive One-Year Results from REVEAL-1 Cohort, Highlighting Revita's Efficacy in Sustaining Weight Loss Post-GLP-1 Therapy - Quiver Quantitative

Revita study shows durable post-GLP-1 weight loss at Fractyl Health (GUTS) - Stock Titan

Fractyl Health Reports Positive One-Year REVEAL-1 - GlobeNewswire

Fractyl Health names Mike Zumdahl as market access head By Investing.com - Investing.com South Africa

Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy - The Manila Times

Fractyl Health names Mike Zumdahl as market access head - Investing.com

Nearly 1M leave GLP-1 therapy monthly; Fractyl hires market-access lead - Stock Titan

Fractyl Health, Inc. Announces Appointment of Mike Zumdahl to Senior Vice President, Market Access and Commercial Strategy - marketscreener.com

Fractyl Health Inc. (GUTS) Declines 2.7% as Stock Tests Critical Support Near $0.78Put Call Ratio - newsline.com

Fractyl Health (GUTS) Dips 3% as Stock Hovers Near Critical Support at $0.85Algorithmic Stock Picks - The Legal Advocate

GUTS Stock Chart | FRACTYL HEALTH INC (NASDAQ:GUTS) - ChartMill

Fractyl Health Q1 earnings call highlights - MSN

Fractyl Health Inc. (GUTS) Q1 2026 Earnings: Narrower Loss Surprises, Stock SlidesEarnings Cycle Report - thelegaladvocate.com

GUTS - Intellectia AI

Fractyl Health’s Pivotal Year: Inside the Earnings Call - TipRanks

Earnings call transcript: Fractyl Health Q1 2026 reports EPS beat, shares surge - Investing.com

Fractyl targets early Q4 2026 REMAIN-1 pivotal readout amid plans for late Q4 2026 de novo submission - MSN

Fractyl Health (GUTS) Is Up 14.0% After First GLP-1 Gene Therapy Trial Win And Profit Turnaround - Yahoo Finance

First human GLP-1 gene therapy trial gets green light - NewsNation

Nantahala’s 16.1M-share stake disclosed in Fractyl Health (NASDAQ: GUTS) - Stock Titan

[SCHEDULE 13G/A] FRACTYL HEALTH, INC. Amended Passive Investment Disclosure - Stock Titan

BofA Securities Maintains Fractyl Health(GUTS.US) With Buy Rating, Announces Target Price $2 - Moomoo

Fractyl Health (GUTS) stock jumps 21% after hours: Here's what you should know - MSN

TradingKey - TradingKey

A Look At Fractyl Health (GUTS) Valuation After New Gene Therapy Trial Approval And First Quarter Net Income - Yahoo Finance

Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA) - The Globe and Mail

SilverArc and Devesh Gandhi report 3.6M shares in Fractyl Health (GUTS) - Stock Titan

Fractyl Health | 10-Q: Q1 2026 Earnings Report - Moomoo

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Morgan Stanley Maintains Fractyl Health(GUTS.US) With Hold Rating, Maintains Target Price $2 - Moomoo

MRNA

$56.39

1.79%

ROIV

$31.18

2.05%

BNTX

$90.59

0.84%

RPRX

$54.15

0.06%

ONC

$263.05

0.89%

RVMD

$157.38

0.51%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters